Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities

This study reports the synthesis of two series of new purine bioisosteres comprising a pyrazolo[3,4-d]pyrimidine scaffold linked to piperazine moiety through different amide linkages. The newly synthesized compounds were evaluated for anticancer activity against four cell lines (MDA-MB-231, MCF-7, S...

Full description

Saved in:
Bibliographic Details
Main Author: Abd El Razik, Heba A. (author)
Other Authors: Mroueh, Mohamad (author), Faour, Wissam H. (author), Shebaby, Wassim N. (author), Daher, Costantine F. (author), Ashour, Hayam M. A. (author), Ragab, Hanan M. (author)
Format: article
Published: 2017
Online Access:http://hdl.handle.net/10725/5366
http://dx.doi.org/10.1111/cbdd.12929
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://onlinelibrary.wiley.com/doi/10.1111/cbdd.12929/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513465842925568
author Abd El Razik, Heba A.
author2 Mroueh, Mohamad
Faour, Wissam H.
Shebaby, Wassim N.
Daher, Costantine F.
Ashour, Hayam M. A.
Ragab, Hanan M.
author2_role author
author
author
author
author
author
author_facet Abd El Razik, Heba A.
Mroueh, Mohamad
Faour, Wissam H.
Shebaby, Wassim N.
Daher, Costantine F.
Ashour, Hayam M. A.
Ragab, Hanan M.
author_role author
dc.creator.none.fl_str_mv Abd El Razik, Heba A.
Mroueh, Mohamad
Faour, Wissam H.
Shebaby, Wassim N.
Daher, Costantine F.
Ashour, Hayam M. A.
Ragab, Hanan M.
dc.date.none.fl_str_mv 2017-03-14T12:15:18Z
2017-03-14T12:15:18Z
2017
2017-03-14
dc.identifier.none.fl_str_mv 1747-0277
http://hdl.handle.net/10725/5366
http://dx.doi.org/10.1111/cbdd.12929
Abd El Razik, H. A., Mroueh, M., Faour, W. H., Shebaby, W. N., Daher, C. F., Ashour, H., & Ragab, H. M. (2017). Synthesis of new pyrazolo [3, 4‐d] pyrimidine derivatives and evaluation of their anti‐inflammatory and anticancer activities. Chemical Biology & Drug Design 90 (1), 83-96
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://onlinelibrary.wiley.com/doi/10.1111/cbdd.12929/full
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Chemical biology & drug design
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description This study reports the synthesis of two series of new purine bioisosteres comprising a pyrazolo[3,4-d]pyrimidine scaffold linked to piperazine moiety through different amide linkages. The newly synthesized compounds were evaluated for anticancer activity against four cell lines (MDA-MB-231, MCF-7, SF-268, B16F-10) and cyclooxygenase (COX-2) protein expression inhibition in lipopolysaccharide (LPS)-activated rat monocytes. The results revealed that most of the synthesized compounds showed moderate-to-high cytotoxic activity against at least one cell line, with compound 10b being the most active against all used cell lines (IC50 values 5.5–11 μg/ml) comparable to cisplatin. In addition, six of these compounds (7b, 10a–d, and 12c) demonstrated inhibition of LPS-induced COX-2 protein expression at low concentration (25 μg/ml) as compared to the control non-stimulated cells and showed a COX-2 selectivity index range comparable to diclofenac sodium. The overall results indicate that many of these pyrazolopyrimidine derivatives possess in vitro anti-inflammatory and anticancer activities at varying doses, and the most active compounds will be subjected to in vivo pharmacological evaluation.
eu_rights_str_mv openAccess
format article
id LAURepo_3532a31af3fed12d17776cc3fc440ccb
identifier_str_mv 1747-0277
Abd El Razik, H. A., Mroueh, M., Faour, W. H., Shebaby, W. N., Daher, C. F., Ashour, H., & Ragab, H. M. (2017). Synthesis of new pyrazolo [3, 4‐d] pyrimidine derivatives and evaluation of their anti‐inflammatory and anticancer activities. Chemical Biology & Drug Design 90 (1), 83-96
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/5366
publishDate 2017
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activitiesAbd El Razik, Heba A.Mroueh, MohamadFaour, Wissam H.Shebaby, Wassim N.Daher, Costantine F.Ashour, Hayam M. A.Ragab, Hanan M.This study reports the synthesis of two series of new purine bioisosteres comprising a pyrazolo[3,4-d]pyrimidine scaffold linked to piperazine moiety through different amide linkages. The newly synthesized compounds were evaluated for anticancer activity against four cell lines (MDA-MB-231, MCF-7, SF-268, B16F-10) and cyclooxygenase (COX-2) protein expression inhibition in lipopolysaccharide (LPS)-activated rat monocytes. The results revealed that most of the synthesized compounds showed moderate-to-high cytotoxic activity against at least one cell line, with compound 10b being the most active against all used cell lines (IC50 values 5.5–11 μg/ml) comparable to cisplatin. In addition, six of these compounds (7b, 10a–d, and 12c) demonstrated inhibition of LPS-induced COX-2 protein expression at low concentration (25 μg/ml) as compared to the control non-stimulated cells and showed a COX-2 selectivity index range comparable to diclofenac sodium. The overall results indicate that many of these pyrazolopyrimidine derivatives possess in vitro anti-inflammatory and anticancer activities at varying doses, and the most active compounds will be subjected to in vivo pharmacological evaluation.PublishedN/A2017-03-14T12:15:18Z2017-03-14T12:15:18Z20172017-03-14Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1747-0277http://hdl.handle.net/10725/5366http://dx.doi.org/10.1111/cbdd.12929Abd El Razik, H. A., Mroueh, M., Faour, W. H., Shebaby, W. N., Daher, C. F., Ashour, H., & Ragab, H. M. (2017). Synthesis of new pyrazolo [3, 4‐d] pyrimidine derivatives and evaluation of their anti‐inflammatory and anticancer activities. Chemical Biology & Drug Design 90 (1), 83-96http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttp://onlinelibrary.wiley.com/doi/10.1111/cbdd.12929/fullenChemical biology & drug designinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/53662024-02-01T12:49:14Z
spellingShingle Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities
Abd El Razik, Heba A.
status_str publishedVersion
title Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities
title_full Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities
title_fullStr Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities
title_full_unstemmed Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities
title_short Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities
title_sort Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities
url http://hdl.handle.net/10725/5366
http://dx.doi.org/10.1111/cbdd.12929
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
http://onlinelibrary.wiley.com/doi/10.1111/cbdd.12929/full